IRCCS-Fondazione Pascale

Naples 80131

0 studies enrolling now · 2 studies all time

What they study most

Prostatic Neoplasms, Castration-Resistant, Urothelial Cancer

Studies at this site

• A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling
• A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations — Running, not enrolling